Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes

Diabet Med. 2017 Mar;34(3):426-431. doi: 10.1111/dme.13264. Epub 2016 Oct 15.

Abstract

Aim: It is unclear whether ketosis-prone diabetes is a specific type or a subtype of Type 2 diabetes. We aimed to describe the clinical and metabolic features of ketosis-prone diabetes in a sub-Saharan population.

Methods: We consecutively enrolled and characterized 173 people with non-autoimmune diabetes admitted for hyperglycaemic crisis at the Yaoundé Central Hospital, Cameroon. Blood samples were collected for fasting glucose, HbA1c , lipid profile and C-peptide assays with insulin resistance and secretion estimation by homeostasis model assessment. People were classified as having Type 2 diabetes (n = 124) or ketosis-prone diabetes (n = 49). Ketosis-prone diabetes was sub-classified as new-onset ketotic phase (n = 34) or non-ketotic phase (n = 15).

Results: Ketosis-prone diabetes was found in 28.3% of the hyperglycaemic crises. Age at diabetes diagnosis was comparable in Type 2 and ketosis-prone diabetes [48 ± 14 vs 47 ± 11 years; P = 0.13] with a similar sex distribution. Overall BMI was 27.7 ± 13.4 kg/m2 and was ≥ 25 kg/m2 in 55.8% of those taking part, however, 73.5% of those with ketosis-prone diabetes reported weight loss of > 5% at diagnosis. Blood pressure and lipid profile were comparable in both types. Ketosis-prone diabetes in the ketotic phase was characterized by lower insulin secretion and higher serum triglycerides compared with non-ketotic ketosis prone and Type 2 diabetes. Type 2 and ketosis prone diabetes in the non-ketotic phase were comparable in terms of lipid profile, blood pressure, waist-to-hip ratio, BMI and fat mass, insulin secretion and insulin resistance indices.

Conclusions: Ketosis-prone diabetes is likely to be a subtype of Type 2 diabetes with the potential to develop acute insulinopenic episodes.

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Cameroon
  • Combined Modality Therapy
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 / diagnosis*
  • Diabetes Mellitus, Type 2 / ethnology
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / therapy
  • Diabetic Ketoacidosis / diagnosis*
  • Diabetic Ketoacidosis / ethnology
  • Diabetic Ketoacidosis / metabolism
  • Diabetic Ketoacidosis / therapy
  • Diagnosis, Differential
  • Female
  • Glycated Hemoglobin / analysis
  • Hospitals, Urban
  • Humans
  • Hyperglycemia / prevention & control*
  • Insulin / blood
  • Insulin / metabolism
  • Insulin Resistance* / ethnology
  • Insulin Secretion
  • Insulin-Secreting Cells / metabolism
  • Male
  • Middle Aged
  • Referral and Consultation

Substances

  • Glycated Hemoglobin A
  • Insulin
  • hemoglobin A1c protein, human